In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Clomatin Drug Master File in Korea (Clomatin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Clomatin. The MFDS reviews the Clomatin KDMF as part of the drug registration process and uses the information provided in the Clomatin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Clomatin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Clomatin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Clomatin suppliers with KDMF on PharmaCompass.